English Germany Japanese Korean

上海一飞生物科技有限公司 公司信息

公司名称: 上海一飞生物科技有限公司
电话: 021-65675885
电子邮件:customer_service@efebio.com
国籍:中国
网址: http://www.efebio.com
产品总数:11975
112 113 114 115 116 117 118 119 120

公司提供产品列表

Thalidomide-4-NH-PEG1-NH2 TFA 1H-ISOINDOLE-1,3(2H)-DIONE, 4-[[2-(2-AMINOETHOXY)ETHYL]AMINO]-2-(2,6-DIOXO-3-PIPERIDINYL)-, 2,2,2-TR 2490499-21-1
Thalidomide-4-NH-PEG1-NH-Boc 沙利度胺-NH-PEG1-NH-BOC 2154342-17-1
JYS003 L-PROLINAMIDE, N-[4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOBUTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[ 2361119-87-9
Ergosinine 異麥角生鹼 596-88-3
Erlizumab 厄利珠单抗 211323-03-4
2,6-Diethylnaphthalene 2,6-二乙基萘 59919-41-4
Thalidomide-NH-(CH2)2-NH-Boc 沙利度胺-NH-C2-NH-Boc 1957235-57-2
Roledumab ROLEDUMAB ( 罗来度单抗 ) 1174008-79-7
Bimagrumab Bimagrumab 1356922-05-8
Vandortuzumab Vandortuzumab Vedotin 1471985-92-8
Dezamizumab Dezamizumab 1662664-56-3
Ieramilimab 埃拉利单抗 2137049-37-5
2,3,4-Trichlorophenol acetate 2,3,4-三氯苯酚乙酸酯 61925-89-1
Capromab CAPROMAB 145464-28-4
Derlotuximab Cotara (9CI) 340013-96-9
Clothianidin-urea Urea, N-[(2-chloro-5-thiazolyl)methyl]-N'-methyl- 634192-72-6
Landogrozumab Landogrozumab 1391726-30-9
Vadastuximab Vadastuximab 1436390-63-4
Ivuxolimab IVUXOLIMAB (艾沃利单抗 ) 2225940-98-5
Altumomab 阿妥莫单抗 156586-92-4
3,4,5-Trichlorophenol acetate 3,4,5-三氯苯酚乙酸酯 59190-61-3
Indatuximab Indatuximab Ravtansine 1238517-16-2
JYS007 L-PROLINAMIDE, N-(12,12-DIMETHYL-1,10-DIOXO-3,6,11-TRIOXA-9-AZATRIDEC-1-YL)-3-METHYL-L-VALYL-4-HYDRO 2162120-75-2
Nofetumomab Merpentan 165942-79-0
JYS005 L-PROLINAMIDE, N-[8-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-OXOOCTYL]-3-METHYL-L-VALYL-4-HYDROXY-N-[ 2306389-02-4
JYS006 L-PROLINAMIDE, N-[2-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHOXY]ACETYL]-3-METHYL-L-VALYL-4-HYDROX 2409007-41-4
Ecromeximab Kw-2871 292819-64-8
5,10,15,20-Tetraoxatetracosane-1,24-diol 5,10,15,20-四氧辛酸酯-1,24-二醇 61136-08-1
Oportuzumab Oportuzumab Monatox 945228-48-8
Denintuzumab Denintuzumab Mafodotin 1399672-02-6
Olendalizumab Olendalizumab 1337966-73-0
Balstilimab BALSTILIMAB (巴替利单抗 ) 2230167-06-1
Thalidomide-NH-CH2-COO(t-Bu) 沙利度胺-NH-C2-NH-COO(T-BU) 2093386-23-1
Stamulumab 司他莫鲁 705287-60-1
Imciromab 英西单抗 126132-83-0
Zolimomab 阿佐莫单抗 141483-72-9
Thalidomide-5-O-CH2-COO(t-Bu) ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-5-YL]OXY]-, 1,1-DIME 2682112-10-1
VH032-NH-CO-CH2-NHBoc VH032-BOC-氨基 2010986-19-1
Arcitumomab 阿西莫单抗 154361-48-5
PBB No. 53 2,2,5,6-四溴联苯 60044-25-9
Narnatumab Narnatumab 1188275-92-4
Coltuximab Coltuximab Ravtansine 1269764-99-9
Ontamalimab Ontamalimab 2098790-40-8
Cibisatamab 赛必妥单抗 2101242-53-7
VH032-NH-CO-CH2-Br 2379404-33-6
Sudan Black B Impurity 1 苏旦黑B杂质1 65322-64-7
Thalidomide-NH-(CH2)3-NH-Boc 沙利度胺-NH-C3-NH-BOC 2093386-36-6
Thalidomide-4-NH-PEG1-COO(t-Bu) PROPANOIC ACID, 3-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]ETHO 2140807-19-6
Biciromab Biciromab 138783-13-8
6-Nitrobenz[a]pyrene 6-硝基苯并(A)芘 63041-90-7
Romosozumab ROMOSOZUMAB 909395-70-6
Tacatuzumab Yttrium (90Y) Tacatuzumab Tetraxetan 476413-07-7
Actoxumab Actoxumab 1245634-25-6
Refanezumab Refanezumab 1233953-61-1
Cusatuzumab 古妥珠单抗 1399546-01-0
Tabituximab Tabituximab 1644134-10-0
Glucuronic Acid 葡糖醛酸 576-37-4
caffeic acid glucoside 咖啡酰葡萄糖苷 892501-29-0
Satumomab 沙妥莫单抗 144058-40-2
JYS002 1448189-66-9
JYS008 VH032-甲基-BOC 2827750-24-1
JYS004 VH032-BOC-丁胺 2412055-00-4
Ertumaxomab ertumaxomab 509077-99-0
Mapatumumab Mapatumumab 658052-09-6
Besilesomab Besilesomab 537694-98-7
PBB No. 26 2,3',5-三溴联苯 59080-35-2
Alacizumab 培戈-阿拉赛珠单抗 934216-54-3
Domagrozumab Domagrozumab 1629605-31-7
Apamistamab Iodine (131I) Apamistamab 2097132-02-8
Sirtratumab Sirtratumab 1824663-82-2
Thalidomide-5-NH-CH2-COO(t-Bu) THALIDOMIDE-5-NH-CH2-COO(T-BU) 2412056-28-9
JYS001 2111829-84-4
PBB-No. 49 2,2',4,5'-四溴联苯 60044-24-8
2,2＇,5-Tribromobiphenyl 2,2,5-三溴联苯 59080-34-1
Otlertuzumab Otlertuzumab 1372645-37-8
Pateclizumab 帕替组单抗 1202526-59-7
Evinacumab Evinacumab 1446419-85-7
4-Cyano-4'-undecylbiphenyl 4-氰基-4'-十一烷基联苯 65860-74-4
Lintuzumab Lintuzumab 166089-32-3
Nacolomab Tafenatox Nacolomabtafenatox 150631-27-9
Naptumomab Estafenatox 埃托-那普妥莫单抗 676258-98-3
PCB No. 50 2,2',4,6-四氯联苯 62796-65-0
Dinutuximab dinutuximab 1363687-32-4
Radretumab RADRETUMAB ( 雷曲妥单抗 ) 1253180-81-2
Ifabotuzumab IFABOTUZUMAB 1234137-51-9
Samrotamab Samrotamab 2052591-32-7
Tamrintamab TAMRINTAMAB (他林妥单抗 ) 2148325-59-9
Thalidomide-4-NH-PEG2-COO(t-Bu) PROPANOIC ACID, 3-[2-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]E 2140807-16-3
Thalidomide-4-NH-PEG3-NH-Boc (2-(2-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚-4-基)氨基)乙氧基)乙氧基)乙氧基)乙基叔丁基)氨基甲酸酯 2204246-03-5
4'-Cyano-4-nonyloxybiphenyl 9OCB 58932-13-1
JYS009 VH032-丙基-BOC 2827750-25-2
Tositumomab bexxar 208921-02-2
Carbophenothion-methyl-sulfone 甲基三硫磷砜, 10ΜG /ΜL于环己烷 62059-34-1
1,2-Dichlorobutane 1,2-二氯丁烷 616-21-6
Oregovomab OregovoMab 213327-37-8
Testosterone-d4 [2H4] - 睾酮 638163-36-7
HuCC49 823788-82-5
Perakizumab 培拉凯珠单抗 1331830-76-2
Clivatuzumab Clivatuzumab Tetraxetan 1462876-11-4
Thalidomide-4-O-CH2-COO(t-Bu) 2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酸叔丁酯 1950635-36-5
112 113 114 115 116 117 118 119 120
Copyright 2007© ChemicalBook. All rights reserved.